Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

Janssen Pharmaceutica’s Acquisition by Eli Lilly’s Animal Health Division

March 16, 2011

On March 15, 2011, Elanco, the animal health division of Eli Lilly and Company (“Lilly”), announced that Lilly has made an irrevocable, unconditional offer to acquire the animal health business of Janssen Pharmaceutica NV, a Johnson & Johnson Company. Cravath represented Janssen Pharmaceutica in connection with this transaction. Financial terms were not disclosed. Headquartered in Beerse, Belgium, Janssen Pharmaceutica’s animal health business is primarily European-focused, targeting disease segments in companion animals and livestock. Closing of the transaction is contingent upon clearance from European regulatory authorities and is subject to other customary closing conditions.

The Cravath team included partner Robert I. Townsend and associates Benjamin P. Schaye, Jason S. Kollander and Katerina M. Novak on corporate matters; partner Andrew W. Needham and associate J. Leonard Teti II on tax matters; and partner Eric W. Hilfers and associates Jarrett R. Hoffman and Michael J. Schobel on executive compensation and benefits matters.

Related Practices & Industries

  • Corporate
  • Mergers and Acquisitions
  • Tax
  • Executive Compensation and Benefits
  • Healthcare and Life Sciences

People

Photo
Name
Robert I. Townsend III
Title
Corporate
Title
Partner
Email
rtownsend@cravath.com
Phone
+1-212-474-1964
vCard
Download vCard

    Education

    • J.D., 1990, Harvard Law School
      magna cum laude
    • A.B., 1987, Harvard College
      magna cum laude

    Admitted In

    • New York
    Photo
    Name
    Eric W. Hilfers
    Title
    Executive Compensation and Benefits
    Title
    Partner
    Email
    ehilfers@cravath.com
    Phone
    +1-212-474-1352
    vCard
    Download vCard

      Education

      • J.D., 1998, University of Chicago Law School
        with Honors
      • A.B., 1995, Princeton University

      Admitted In

      • New York
      Photo
      Name
      J. Leonard Teti II
      Title
      Tax
      Title
      Partner
      Email
      lteti@cravath.com
      Phone
      +1-212-474-1896
      vCard
      Download vCard

        Education

        • J.D., 2005, University of Virginia School of Law
          Order of the Coif
        • A.B., 1999, Princeton University
          with Honors

        Admitted In

        • New York
        Photo
        Name
        Andrew W. Needham
        Title
        Tax
        Title
        Retired Partner
        Email
        aneedham@cravath.com
        Phone
        +1-212-474-9999
        vCard
        Download vCard

          Education

          • M.B.A., 1992, The Wharton School of the University of Pennsylvania
          • LL.M., 1990, Georgetown University Law Center
          • J.D., 1986, Georgetown University Law Center
          • B.A., 1982, University of Arizona College of Law

          Related News & Insights

          Deals & Cases

          March 12, 2025

          Johnson & Johnson’s $5 Billion Registered Notes Offering and Concurrent €4 Billion Notes Offering

          Cravath represented the underwriters in connection with the $5 billion registered notes offering of Johnson & Johnson, the world’s largest, most diversified healthcare products company. Cravath also represented the underwriters in connection with Johnson & Johnson’s concurrent €4 billion notes offering. Proceeds of both offerings will be used to finance the acquisition of Intra‑Cellular Therapies, Inc. by Johnson & Johnson. The transactions closed on February 20, 2025, and February 26, 2025, respectively.

          Deals & Cases

          October 12, 2023

          Williams Secures Delaware Supreme Court Victory Affirming Trial Win with $600 Million Judgment

          On October 10, 2023, following a full trial on the merits and an appeal to the Delaware Supreme Court, Cravath client The Williams Companies, Inc. (“Williams”) secured a victory resulting in a judgment of more than $600 million.

          Cravath Bicentennial

          Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

          Explore

          Cravath, Swaine & Moore LLP Logo
          • CONTACT US
          • OUR STORY
          • ALUMNI PORTAL
          • DISCLAIMERS & NOTICES

          Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.